Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    19114685 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
PACCE: Panitumumab Advanced Colorectal Cancer Evaluation Study
Condition: Colorectal Cancer
Interventions: Drug: Oxaliplatin Based Chemotherapy;   Drug: Panitumumab;   Drug: Irinotecan Based Chemotherapy;   Drug: Bevacizumab

Indicates status has not been verified in more than two years